A Trial Evaluating the Pharmacokinetics and Mode of Action of EndoTAG®-1 in Tumor Patients With Hepatic Metastases

Clinical trial NCT00542048 · COMPLETED

Trial details

NCT number: NCT00542048
Sponsor: MediGene
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Liver Cancer Neoplasm Metastasis

Start date: 2007-11-01
Primary completion: 2009-09-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.